Clarithromycin Dosage for Community-Acquired Pneumonia

Dosage Recommendations

The American Thoracic Society recommends clarithromycin 500 mg twice daily for 7 days for outpatients with community-acquired pneumonia (CAP) as an immediate-release formulation 1, 2
The American Thoracic Society recommends clarithromycin 1000 mg (1 gram) once daily for 7 days for outpatients with CAP as an extended-release formulation 1, 2
For healthy outpatients without comorbidities, clarithromycin can be used as monotherapy (500 mg twice daily or extended-release 1000 mg daily) only in areas with pneumococcal resistance to macrolides <25% 1, 2
The American Thoracic Society recommends alternative options such as amoxicillin 1 g three times daily or doxycycline 100 mg twice daily for outpatients with CAP 1, 2

For outpatients with comorbidities, clarithromycin should be used as part of combination therapy with a β-lactam (not as monotherapy) 1, 2
The American Thoracic Society recommends a combination of amoxicillin/clavulanate or cephalosporin PLUS clarithromycin 500 mg twice daily or extended-release 1000 mg daily for outpatients with comorbidities 1, 2
For hospitalized non-ICU patients, clarithromycin 500 mg twice daily in combination with a β-lactam (ampicillin/sulbactam, cefotaxime, ceftriaxone, or ceftaroline) is recommended 3

Numerous randomized clinical trials have documented the efficacy of clarithromycin as monotherapy for outpatient CAP, according to the Infectious Diseases Society of America 4
Monotherapy with a macrolide (including clarithromycin) is not recommended for patients with significant risk of drug-resistant S. pneumoniae infection, as stated by the Infectious Diseases Society of America 4
For patients who have received antibiotics in the previous 3 months, the Infectious Diseases Society of America recommends avoiding using an agent from the same class 4
Clinical failure can occur with macrolide-resistant isolates, particularly in patients with risk factors, according to the Infectious Diseases Society of America 4

For hospitalized non-ICU patients, clarithromycin 500 mg twice daily in combination with a β-lactam (ampicillin/sulbactam, cefotaxime, ceftriaxone) is recommended, according to the Clinical Microbiology and Infection guidelines 5
For severe CAP requiring ICU care, clarithromycin 500 mg twice daily IV can be used in combination with a broad-spectrum β-lactam, as suggested by the Clinical Microbiology and Infection guidelines 5, 6

For Chlamydophila pneumoniae, clarithromycin 500 mg PO twice daily for 10 days is recommended, as per the Journal of Microbiology, Immunology and Infection guidelines 7
For Legionella species, clarithromycin 500 mg PO twice daily is an alternative to levofloxacin or azithromycin, according to the Journal of Microbiology, Immunology and Infection guidelines 7
For Mycoplasma pneumoniae, clarithromycin is an alternative to doxycycline, as suggested by the Thorax guidelines 8

Treatment should generally not exceed 8 days in a responding patient, according to the Clinical Microbiology and Infection guidelines 5
For specific pathogens like Legionella, longer courses (10-14 days) may be needed, as per the Journal of Microbiology, Immunology and Infection guidelines 7